Boryung Pharm - Asset Resilience Ratio

Latest as of September 2025: 8.59%

Boryung Pharm (003850) has an Asset Resilience Ratio of 8.59% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

₩116.42 Billion

≈ $78.89 Million USD Cash + Short-term Investments

Total Assets

₩1.36 Trillion

≈ $918.96 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2009–2024)

This chart shows how Boryung Pharm's Asset Resilience Ratio has changed over time. Check Boryung Pharm (003850) strategic asset index to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Boryung Pharm's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Boryung Pharm worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩116.42 Billion	8.59%
Total Liquid Assets	₩116.42 Billion	8.59%

Asset Resilience Insights

Limited Liquidity: Boryung Pharm maintains only 8.59% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Boryung Pharm Industry Peers by Asset Resilience Ratio

Compare Boryung Pharm's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Shan Dong Dong-E E-Jiao Co Ltd SHE:000423	Drug Manufacturers - Specialty & Generic	20.44%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	48.48%
Tasly Pharmaceutical Group Co Ltd SHG:600535	Drug Manufacturers - Specialty & Generic	11.69%
Chengdu Kanghong Pharmaceuticals Group Co Ltd SHE:002773	Drug Manufacturers - Specialty & Generic	4.31%
Tibet Rhodiola Pharmaceutical Holding Co SHG:600211	Drug Manufacturers - Specialty & Generic	15.57%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Changzhou Qianhong Biopharma Co Ltd SHE:002550	Drug Manufacturers - Specialty & Generic	18.70%

Annual Asset Resilience Ratio for Boryung Pharm (2009–2024)

The table below shows the annual Asset Resilience Ratio data for Boryung Pharm.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.40%	₩4.67 Billion ≈ $3.17 Million	₩1.16 Trillion ≈ $788.89 Million	+0.01pp
2023-12-31	0.39%	₩3.59 Billion ≈ $2.44 Million	₩915.51 Billion ≈ $620.43 Million	+0.19pp
2022-12-31	0.21%	₩1.84 Billion ≈ $1.25 Million	₩892.39 Billion ≈ $604.76 Million	-5.92pp
2021-12-31	6.12%	₩50.73 Billion ≈ $34.38 Million	₩828.64 Billion ≈ $561.56 Million	-3.94pp
2020-12-31	10.06%	₩65.21 Billion ≈ $44.19 Million	₩647.99 Billion ≈ $439.14 Million	+10.02pp
2019-12-31	0.04%	₩213.73 Million ≈ $144.85K	₩507.63 Billion ≈ $344.01 Million	-0.01pp
2018-12-31	0.05%	₩213.18 Million ≈ $144.47K	₩450.02 Billion ≈ $304.97 Million	-0.01pp
2017-12-31	0.05%	₩214.70 Million ≈ $145.50K	₩402.52 Billion ≈ $272.78 Million	-0.05pp
2016-12-31	0.10%	₩410.37 Million ≈ $278.10K	₩397.90 Billion ≈ $269.65 Million	+0.10pp
2012-12-31	0.00%	₩3.82 Million ≈ $2.59K	₩273.01 Billion ≈ $185.01 Million	0.00pp
2011-12-31	0.00%	₩3.76 Million ≈ $2.55K	₩262.39 Billion ≈ $177.82 Million	+0.00pp
2010-12-31	0.00%	₩2.29 Million ≈ $1.55K	₩245.86 Billion ≈ $166.61 Million	0.00pp
2009-12-31	0.00%	₩2.29 Million ≈ $1.55K	₩176.79 Billion ≈ $119.80 Million	--

pp = percentage points

About Boryung Pharm

KO:003850 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$468.89 Million

₩691.90 Billion KRW

Market Cap Rank

#12361 Global

#326 in Korea

Share Price

₩8190.00

Change (1 day)

+4.33%

52-Week Range

₩7570.00 - ₩10680.00

All Time High

₩21257.60